SQUAWK/NEWS
Account
Theme
Account
Menu
Live News NEWS FLASH L impact

AbCellera Biologics Initiated at Overweight by JP Morgan

Ratings actions GMT) AbCellera Biologics Price Target Announced at $17.00/Share by JP MorganRatings actions

ABCL